Ross Fiziol Zh Im I M Sechenova
November 2014
The analysis of retainment and release kinetics of deposited in tissue structures calcium was made in the hypercalcemic conditions in 28 healthy volunteers (22 males and 6 females) of the age of 33 ± 6.5 years via drip infusion (Groups 1, 2) and in 9 individuals (3 males and 6 females) in 12 trials via stream infusion (Group 3). By the end of each hour after the termination of calcium infusion the amount of calcium retained in tissues was calculated (Mtis.
View Article and Find Full Text PDFCalcium binding kinetic by tissue structures was analysed in 19 health volunteers (13 men and 6 women) of the age group of 33 +/- 6.5 under conditions of acute hypercalcaemia followed by a drip i.v.
View Article and Find Full Text PDFThe sample of 45 recipients (30 females and 15 males) after orthotopic transplantation of liver was examined thrice in dynamics. Three groups were formed according the resulted values of T-criterion of bone mineral density in the area of lumbar vertebrae. The bone mineral density of group A was considered as osteoporosis, of group B as osteopenia and of group C as physiologic norm.
View Article and Find Full Text PDFThe biochemical bone formation marker aminoterminal type 1 procollagen propeptide (total P1NP) was determined in 91 serum samples from healthy male donors aged 19 to 60 years, by using an "Elecsys Total P1NP" kit of reagents ("Roche-Diagnostics", Germany) on an "Elecsys 2010" electric chemiluminescence analyzer ("Roche-Hitachi", Japan). A relationship was found between the serum concentration of total P1NP and the age of the examined males. At the age of 19-20 years, the content of the propeptide is highest, at the age of 21-24 years, it decreased by 1.
View Article and Find Full Text PDFAim: To ascertain informative value of estimation of bone forming markers in patients on chronic hemodyalisis (CHD) and recipients of cadaveric kidney (CK).
Material And Methods: Parathyroid hormone (PTH), beta-crosslaps (CTX), osteocalcin (OC), amino-terminal procollagen propeptide 1 (PINP), bone alkaline phosphatase (BAP), bone mineral density (BMD) were determined in 152 patients on CHD (89 males and 63 females aged 49 +/- 13 years) and 195 CK recipients (106 males and 89 females aged 42 +/- 12 years) 30 +/- 38 months after kidney transplantation.
Results: PTH, CTX and BAP determination specifies skeletal disease (secondary hyperparathyroidism or adynamic bone disease) in CHD patients.